Zobrazeno 1 - 10
of 44
pro vyhledávání: '"H19 lncRNA"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Abhishek Dey
Publikováno v:
Non-Coding RNA, Vol 9, Iss 4, p 45 (2023)
Pre-miR-675 is a microRNA expressed from the exon 1 of H19 long noncoding RNA, and the atypical expression of pre-miR-675 has been linked with several diseases and disorders including cancer. To execute its function inside the cell, pre-miR-675 is fo
Externí odkaz:
https://doaj.org/article/0858e78d3fff45d597b49094e295c2d6
Autor:
Ki-Sun Park, Beenish Rahat, Hyung Chul Lee, Zu-Xi Yu, Jacob Noeker, Apratim Mitra, Connor M Kean, Russell H Knutsen, Danielle Springer, Claudia M Gebert, Beth A Kozel, Karl Pfeifer
Publikováno v:
eLife, Vol 10 (2021)
Maternal loss of imprinting (LOI) at the H19/IGF2 locus results in biallelic IGF2 and reduced H19 expression and is associated with Beckwith–-Wiedemann syndrome (BWS). We use mouse models for LOI to understand the relative importance of Igf2 and H1
Externí odkaz:
https://doaj.org/article/9585b4d7825b4eb19926c26cb2be1f3c
Publikováno v:
Cancer Management and Research, Vol Volume 11, Pp 2059-2072 (2019)
Wei-Quan Liang,1,* De Zeng,2,* Chun-Fa Chen,1 Shu-Ming Sun,1 Xiao-Feng Lu,1 Chun-yan Peng,3 Hao-Yu Lin1 1Department of Thyroid and Breast Surgery, The First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong 515000, People
Externí odkaz:
https://doaj.org/article/53d3f67c44014129a844ba2f091e42fe
Autor:
An Xu, Mo-Fan Huang, Dandan Zhu, Julian A. Gingold, Danielle A. Bazer, Betty Chang, Donghui Wang, Chien-Chen Lai, Ihor R. Lemischka, Ruiying Zhao, Dung-Fang Lee
Publikováno v:
Frontiers in Genetics, Vol 11 (2021)
Osteosarcoma is one of the most frequent common primary malignant tumors in childhood and adolescence. Long non-coding RNAs (lncRNAs) have been reported to regulate the initiation and progression of tumors. However, the exact molecular mechanisms inv
Externí odkaz:
https://doaj.org/article/9e84eebc8a7546098fc8ae81b9b148a8
Publikováno v:
Cellular & Molecular Biology Letters, Vol 22, Iss 1, Pp 1-10 (2017)
Abstract Background H19 is a well-characterized Long noncoding RNA (lncRNA) that has been proven to promote myoblast differentiation in humans and mice. However, its mechanism of action is still not fully interpreted. Methods Using RT-qPCR, we examin
Externí odkaz:
https://doaj.org/article/2169786f7fa046b78a01529856308d4e
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Danielle A. Springer, Claudia Gebert, Zu-Xi Yu, Beenish Rahat, Karl Pfeifer, Connor M Kean, Russell H Knutsen, Ki-Sun Park, Hyung Chul Lee, Apratim Mitra, Beth A. Kozel, Jacob Noeker
Publikováno v:
eLife, Vol 10 (2021)
eLife
eLife
Maternal loss of imprinting (LOI) at the H19/IGF2 locus results in biallelic IGF2 and reduced H19 expression and is associated with Beckwith–-Wiedemann syndrome (BWS). We use mouse models for LOI to understand the relative importance of Igf2 and H1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::424f807a4c02e8ae3e49f294705470da
https://doi.org/10.7554/elife.67250
https://doi.org/10.7554/elife.67250
Autor:
Alessio D'Alessio, Gigliola Sica, Gabriella Proietti, Barbara Fazi, Elena Binda, Angelo L. Vescovi, Annunziato Mangiola, Laura Masuelli, Cristiana Angelucci, Gina Lama, Silvia Anna Ciafrè, Roberto Bei
Publikováno v:
Oncotarget
In glioblastoma multiforme (GBM), cancer stem cells (CSCs) are thought to be responsible for gliomagenesis, resistance to treatment and recurrence. Unfortunately, the prognosis for GBM remains poor and recurrence frequently occurs in the peritumoral
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e1af61f9e0cffdd961e36cf47dcb91d
https://doi.org/10.18632/oncotarget.25565
https://doi.org/10.18632/oncotarget.25565